Cover Image
Market Research Report
Product code 
1068461

UAE IVF Drugs and Food Supplements Market, by Product Type (Drugs (Clomiphene, Injectable Hormones, and Food Supplements), and by Distribution Channel - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published: | Coherent Market Insights | 198 Pages | Delivery time: 2-3 business days

Price

Back to Top
UAE IVF Drugs and Food Supplements Market, by Product Type (Drugs (Clomiphene, Injectable Hormones, and Food Supplements), and by Distribution Channel - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Published: February 23, 2022
Coherent Market Insights
Content info: 198 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

In vitro fertilization (IVF) is a form of assisted reproductive technology in which a woman's reproductive system is artificially stimulated to produce oocytes, which are extracted, fertilized in a laboratory, and then implanted in the uterus. This is a multistep process that needs to be carefully controlled with the use of medications due to the complex interplay of the various drugs used to replicate the different stages of the fertilization process by IVF healthcare team. IVF is a multistep process involving ovarian stimulation, ovulation induction, collection of oocytes, fertilization with sperm, and transfer of the fertilized oocytes to the uterus for implantation and maturation by following various stages. At each stage, there are different protocols for the use of these drugs, and the most appropriate pharmacologic regimen and therapeutic intervention are chosen after a thorough pre-treatment evaluation and an accurate diagnosis, controlled ovarian stimulation is achieved with the use of gonadotropin-releasing hormone (GnRH) analogues and inhibitors of natural steroid hormones, such as clomiphene citrate, recombinant follicle-stimulating hormone (FSH), and luteinizing hormone (LH) and also by providing food supplements to patients, such as Coenzyme Q10 (CoQ10) and DHEA are two supplements that are often used to help older women (over 35) and those with limited ovarian reserve. These are commonly used by women who are undergoing IVF to boost the number of eggs generated by their ovaries.

Market Dynamics

Key players and market players operating in the market are focusing on expanding and developing efficient IVF facilities which can be attributed to the growth of the UAE IVF drugs and food supplements market. For instance, on November 14, 2021, Mediclinic Middle East, which is a part of Mediclinic International and hospital group that operates seven hospitals in the UAE announced the 100% acquisition of Bourn Hall Fertility Centre, an IVF specialties center in the MENA region from TVM Capital Healthcare, following an initial acquisition of 30% of the shares in December 2018.The aim of this acquisition is to provide the highest level of quality care with exceptional outcomes through this acquisition to provide better services for IVF facilities.

Key features of the study:

  • This report provides an in-depth analysis of the UAE IVF drugs and food supplements, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the UAE IVF drugs and food supplements based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KGaA, and Ferring B.V.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The UAE IVF drugs and food supplements report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the UAE IVF drugs and food supplements market.

Detailed Segmentation:

  • UAE IVF Drugs and Food Supplements Market, by Product Type:
    • Drugs
      • Clomiphene
      • Injectable Hormones
      • Human chorionic gonadotropin (hCG)
      • Follicle-stimulating hormone (FSH)
      • Human menopausal gonadotropin (hMG)
      • Gonadotropin-releasing hormone (GnRH)
      • GnRH agonist
      • GonGnRH antagonist
    • Food Supplements
  • UAE IVF Drugs and Food Supplements Market, by Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Company Profiles
    • Shinelife*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Adorefem
    • LG Chem
    • Adorshea
    • Biofield Pharma
    • Medibyte
    • Mestra Pharma
    • Dr. D Pharma
    • Abbott
    • Zydus
    • Takeda Pharmaceutical Company Limited
    • Merck KGaA
    • Ferring B.V.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4939

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Distribution Channel
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Industry Trends
  • Regulatory Scenario
  • Recent Product Approval/Launches
  • PEST Analysis
  • Porter's Analysis

4. UAE IVF Drugs and Food Supplements Market- Impact of Coronavirus (COVID-19) Pandemic

  • Impact on Demand
  • Impact on Healthcare
  • Epidemiology

5. UAE IVF Drugs and Food Supplements Market, By Product Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
    • Clomiphene
    • Injectable Hormones
    • Human chorionic gonadotropin (hCG)
    • Follicle-stimulating hormone (FSH)
    • Human menopausal gonadotropin (hMG)
    • Gonadotropin-releasing hormone (GnRH)
    • GnRH agonist
    • GonGnRH antagonist
  • Food Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)

6. UAE IVF Drugs and Food Supplements Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Shinelife
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Adorefem
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • LG Chem
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Adorshea
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Biofield Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Medibyte
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Mestra Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Dr. D Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Zydus
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Ferring B.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About Us